The location of cancer patient-derived p85α BH mutations with significant impacts on Rab5 binding (I177, E217) and/or regulation (E137, I177, E217, E297) are shown in the modeled p85α BH domain: Rab5 complex (Fig. 6b). This evidence concerns the gene RAB5A and cancer.